Cargando…
Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest
The atypical E2Fs, E2F7 and E2F8, act as potent transcriptional repressors of DNA replication genes providing them with the ability to induce a permanent S‐phase arrest and suppress tumorigenesis. Surprisingly in human cancer, transcript levels of atypical E2Fs are frequently elevated in proliferati...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830916/ https://www.ncbi.nlm.nih.gov/pubmed/29363506 http://dx.doi.org/10.15252/embj.201797877 |
_version_ | 1783303088685187072 |
---|---|
author | Yuan, Ruixue Vos, Harmjan R van Es, Robert M Chen, Jing Burgering, Boudewijn MT Westendorp, Bart de Bruin, Alain |
author_facet | Yuan, Ruixue Vos, Harmjan R van Es, Robert M Chen, Jing Burgering, Boudewijn MT Westendorp, Bart de Bruin, Alain |
author_sort | Yuan, Ruixue |
collection | PubMed |
description | The atypical E2Fs, E2F7 and E2F8, act as potent transcriptional repressors of DNA replication genes providing them with the ability to induce a permanent S‐phase arrest and suppress tumorigenesis. Surprisingly in human cancer, transcript levels of atypical E2Fs are frequently elevated in proliferating cancer cells, suggesting that the tumor suppressor functions of atypical E2Fs might be inhibited through unknown post‐translational mechanisms. Here, we show that atypical E2Fs can be directly phosphorylated by checkpoint kinase 1 (Chk1) to prevent a permanent cell cycle arrest. We found that 14‐3‐3 protein isoforms interact with both E2Fs in a Chk1‐dependent manner. Strikingly, Chk1 phosphorylation and 14‐3‐3‐binding did not relocate or degrade atypical E2Fs, but instead, 14‐3‐3 is recruited to E2F7/8 target gene promoters to possibly interfere with transcription. We observed that high levels of 14‐3‐3 strongly correlate with upregulated transcription of atypical E2F target genes in human cancer. Thus, we reveal that Chk1 and 14‐3‐3 proteins cooperate to inactivate the transcriptional repressor functions of atypical E2Fs. This mechanism might be of particular importance to cancer cells, since they are exposed frequently to DNA‐damaging therapeutic reagents. |
format | Online Article Text |
id | pubmed-5830916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58309162018-03-14 Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest Yuan, Ruixue Vos, Harmjan R van Es, Robert M Chen, Jing Burgering, Boudewijn MT Westendorp, Bart de Bruin, Alain EMBO J Articles The atypical E2Fs, E2F7 and E2F8, act as potent transcriptional repressors of DNA replication genes providing them with the ability to induce a permanent S‐phase arrest and suppress tumorigenesis. Surprisingly in human cancer, transcript levels of atypical E2Fs are frequently elevated in proliferating cancer cells, suggesting that the tumor suppressor functions of atypical E2Fs might be inhibited through unknown post‐translational mechanisms. Here, we show that atypical E2Fs can be directly phosphorylated by checkpoint kinase 1 (Chk1) to prevent a permanent cell cycle arrest. We found that 14‐3‐3 protein isoforms interact with both E2Fs in a Chk1‐dependent manner. Strikingly, Chk1 phosphorylation and 14‐3‐3‐binding did not relocate or degrade atypical E2Fs, but instead, 14‐3‐3 is recruited to E2F7/8 target gene promoters to possibly interfere with transcription. We observed that high levels of 14‐3‐3 strongly correlate with upregulated transcription of atypical E2F target genes in human cancer. Thus, we reveal that Chk1 and 14‐3‐3 proteins cooperate to inactivate the transcriptional repressor functions of atypical E2Fs. This mechanism might be of particular importance to cancer cells, since they are exposed frequently to DNA‐damaging therapeutic reagents. John Wiley and Sons Inc. 2018-01-23 2018-03-01 /pmc/articles/PMC5830916/ /pubmed/29363506 http://dx.doi.org/10.15252/embj.201797877 Text en © 2018 The Authors. Published under the terms of the CC BY NC ND 4.0 license This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Articles Yuan, Ruixue Vos, Harmjan R van Es, Robert M Chen, Jing Burgering, Boudewijn MT Westendorp, Bart de Bruin, Alain Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest |
title | Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest |
title_full | Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest |
title_fullStr | Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest |
title_full_unstemmed | Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest |
title_short | Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest |
title_sort | chk1 and 14‐3‐3 proteins inhibit atypical e2fs to prevent a permanent cell cycle arrest |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830916/ https://www.ncbi.nlm.nih.gov/pubmed/29363506 http://dx.doi.org/10.15252/embj.201797877 |
work_keys_str_mv | AT yuanruixue chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest AT vosharmjanr chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest AT vanesrobertm chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest AT chenjing chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest AT burgeringboudewijnmt chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest AT westendorpbart chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest AT debruinalain chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest |